BeStock  
Stocks › Biotechnology › PGEN

Precigen PGEN

US equityMarket cap rank #2871Biotechnology
$4.21 +$0.05 (+1.20%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.24 +0.61%
Open$4.16
Prev close$4.16
Day range$4.07 – $4.36
Volume6.07M
Market cap$1.51B
P/E (TTM)38.3
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$74.15M+2,437.6% YoY
Operating profit$38.65M+212.1% YoY
Net profit$35.77M+124.4% YoY
Diluted EPS$0.08+107.5% YoY
Free cash flow$11.45M+138.9% YoY
Operating cash flow$11.88M

Revenue, last 8 quarters

$1.2MDec '24$1.3MMar '25$856.0KJun '25$2.9MSep '25$4.6MDec '25$23.3MMar '26$55.0MJun '26$74.1MSep '26

Net profit, last 8 quarters

$-19.7MDec '24$-54.2MMar '25$-26.6MJun '25$-146.3MSep '25$-23.5MDec '25$-7.9MMar '26$20.1MJun '26$35.8MSep '26

Diluted EPS by quarter

-0.06Dec '24-0.18Mar '25-0.09Jun '25-1.06Sep '25-0.01Dec '25-0.02Mar '260.05Jun '260.08Sep '26

Free cash flow by quarter

$-9.3MDec '24$-16.9MMar '25$-19.9MJun '25$-29.5MSep '25$-23.5MDec '25$-44.1MMar '26$-18.2MJun '26$11.4MSep '26

Annual revenue

$103.2MFY20$14.3MFY21$26.9MFY22$6.2MFY23$3.9MFY24$9.7MFY25

Profitability & balance sheet

Gross margin91.4%
Operating margin21.4%
Net margin15.6%
Return on equity38.8%
Return on assets12.7%
Return on invested capital20.9%
Current ratio5.58
Liabilities / assets60.5%
Cash & investments$46.07M
Total debt$97.47M
Net cash (debt)-$51.40M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Papzimeos$72.94M 98.4%
  • Service Revenues$1.19M 1.6%
  • Exemplar$18,000.00 0.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $74.15M $54.98M $23.25M $9.68M $4.57M
Total Operating Revenue $74.15M $54.98M $23.25M $9.68M $4.57M
Cost of Revenue $6.51M $2.81M $2.56M $4.82M $1.60M
Gross Profit $67.64M $52.17M $20.69M $4.86M $2.97M
Operating Expense $28.99M $29.53M $26.69M $111.46M $24.64M
Selling and Admin Expenses $22.36M $22.25M $21.05M $70.13M $17.65M
Research & Development $6.63M $7.28M $5.64M $41.33M $6.99M
Operating Profit $38.65M $22.64M -$5.99M -$106.60M -$21.67M
Net Non-Operating Interest Income (Expense) -$2.67M -$2.59M -$2.23M -$652,000.00 -$1.90M
Non-Operating Interest Income $323,000.00 $366,000.00 $683,000.00 $3.22M $1.07M
Non-Operating Interest Expense $3.00M $2.95M $2.91M $3.87M $2.96M
Other Income (Expense) -$11,000.00 $16,000.00 $290,000.00 -$143.39M $60,000.00
Special Income (Charges) $0.00 $0.00 – -$3.91M $0.00
-Less:Impairment of Capital Assets $0.00 $0.00 – $3.91M $0.00
Other Non-Operating Income (Expenses) -$11,000.00 $16,000.00 $290,000.00 $43,000.00 $60,000.00
Pretax Profit $35.97M $20.07M -$7.93M -$250.64M -$23.50M
Tax $200,000.00 $0.00 $0.00 $3,000.00 $0.00
Net Profit $35.77M $20.07M -$7.93M -$250.64M -$23.50M
Profit from Continuing Operations $35.77M $20.07M -$7.93M -$250.64M -$23.50M
Net Income to Parent Company $35.77M $20.07M -$7.93M -$250.64M -$23.50M
Net Income to Common Stockholders $35.77M $20.07M -$7.93M -$429.64M -$23.50M
Basic EPS $0.10 $0.06 -$0.02 -$1.37 -$0.01
Diluted EPS $0.08 $0.05 -$0.02 -$1.37 -$0.01
Gain on Sale of Security – – – -$139.52M $0.00
Preferred Stock Dividends – – – $179.00M $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $212.10M $170.30M $138.63M $155.51M $155.51M
Total Current Assets $171.76M $134.38M $101.67M $115.24M $115.24M
Cash and Cash Equivalents & Short-Term Investments $46.07M $38.21M $56.25M $97.86M $97.86M
-Cash and Cash Equivalents $14.96M $16.33M $7.48M $30.23M $30.23M
-Short Term Investments $31.11M $21.88M $48.77M $67.62M $67.62M
Receivables $96.62M $72.04M $26.71M $4.36M $4.36M
-Accounts Receivable $96.49M $71.87M $26.40M $3.92M $3.92M
-Other Receivables $133,000.00 $178,000.00 $302,000.00 $446,000.00 $446,000.00
Inventory $22.92M $20.25M $14.73M $9.58M $9.58M
Other Current Assets $6.16M $3.89M $4.00M $3.43M $3.43M
Total Non-Current Assets $40.34M $35.91M $36.96M $40.27M $40.27M
Net PPE $17.27M $16.87M $17.52M $18.36M $18.36M
-Gross PPE $43.44M $42.25M $42.12M $42.19M $42.19M
-Accumulated Depreciation -$26.18M -$25.38M -$24.60M -$23.82M -$23.82M
Investments and Advances $4.91M $490,000.00 $489,000.00 $2.51M $2.51M
-Available for Sale Securities $4.91M $490,000.00 $489,000.00 $2.51M $2.51M
Goodwill and Other Intangible Assets $17.46M $17.78M $18.10M $18.41M $18.41M
-Goodwill $15.23M $15.23M $15.23M $15.23M $15.23M
-Other Intangible Assets $2.23M $2.55M $2.86M $3.18M $3.18M
Other Non-Current Assets $704,000.00 $771,000.00 $852,000.00 $982,000.00 $982,000.00
Total Liabilities $128.31M $126.72M $118.39M $134.59M $134.59M
Total Current Liabilities $30.79M $29.35M $21.10M $37.31M $37.31M
Payables $7.06M $5.30M $2.59M $11.99M $11.99M
-Accounts Payable $7.06M $5.30M $2.59M $11.99M $11.99M
Current Accrued Expenses $14.57M $16.21M $12.48M $13.47M $13.47M
Short-Term Debt and Capital Lease Obligation $1.14M $1.06M $1.07M $1.14M $1.14M
-Current Capital Lease Obligation $1.14M $1.06M $1.07M $1.14M $1.14M
Current Deferred Liabilities $174,000.00 $284,000.00 $410,000.00 $517,000.00 $517,000.00
Total Non-Current Liabilities $97.52M $97.37M $97.29M $97.29M $97.29M
Long Term Debt and Capital Lease Obligation $97.47M $97.29M $97.18M $97.15M $97.15M
-Long Term Debt $94.26M $93.88M $93.52M $93.17M $93.17M
-Long Term Capital Lease Obligation $3.22M $3.41M $3.66M $3.98M $3.98M
Other Non-Current Liabilities $48,000.00 $77,000.00 $106,000.00 $134,000.00 $134,000.00
Total Equity $83.79M $43.58M $20.24M $20.91M $20.91M
Stockholders' Equity $83.79M $43.58M $20.24M $20.91M $20.91M
Capital Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.38B $2.37B $2.37B $2.36B $2.36B
Retained Earnings -$2.29B -$2.33B -$2.35B -$2.34B -$2.34B
Gains/Losses Not Affecting Retained Earnings -$87,000.00 -$29,000.00 -$17,000.00 $7,000.00 $7,000.00
Derivative Product Liabilities – – – $0.00 $0.00
Non-Current Deferred Liabilities – – – $0.00 $0.00
Convertible preferred securities – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $11.88M -$17.81M -$43.83M -$87.83M -$23.46M
Net cash flow from continuing operations $11.88M -$17.81M -$43.83M -$87.83M -$23.46M
Net Income from Continuing Operations $35.77M $20.07M -$7.93M -$250.64M -$23.50M
Depreciation & Depletion & Amortization $1.11M $1.10M $1.10M $3.20M $1.14M
Other Non-Cash Items $374,000.00 $361,000.00 -$1.61M $146,000.00 -$453,000.00
Change in Working Capital -$28.97M -$42.71M -$38.03M $7.36M -$2.09M
-Change in Receivables -$24.58M -$45.34M -$22.34M -$3.20M -$3.26M
-Change in Inventory -$2.67M -$5.79M -$4.88M -$9.21M -$6.26M
-Change in Prepaid Assets -$2.27M $109,000.00 -$562,000.00 -$93,000.00 $869,000.00
-Change in Payables and Accrued Expense -$728,000.00 $6.47M -$7.89M $15.64M $6.80M
-Change in Other Current Assets $74,000.00 $74,000.00 $126,000.00 -$556,000.00 -$174,000.00
-Change in Other Current Liabilities -$51,000.00 -$61,000.00 -$103,000.00 $125,000.00 -$33,000.00
-Change In Other Working Capital $1.25M $1.82M -$2.38M $4.66M -$25,000.00
Net cash flow from investing -$13.97M $26.69M $20.97M -$1.54M $39.87M
Net Cash Flow from Continuing Investing Activities -$13.97M $26.69M $20.97M -$1.54M $39.87M
Net PPE Purchase and Sale -$435,000.00 -$392,000.00 -$258,000.00 -$2.00M -$18,000.00
Net Investment Purchase and Sale -$13.54M $27.08M $21.23M $460,000.00 $39.88M
Financing Cash Flow $733,000.00 -$33,000.00 $109,000.00 $90.05M -$514,000.00
Net Cash Flow from Continuing Financing Activities $733,000.00 -$33,000.00 $109,000.00 $90.05M -$514,000.00
Net Common Stock Issuance $0.00 $0.00 $0.00 -$1.66M $0.00
Proceeds from Stock Option Exercised $944,000.00 $1.32M $255,000.00 $1.20M $140,000.00
Net Other Financing Charges -$211,000.00 -$1.35M -$146,000.00 -$1.78M $537,000.00
Ending Cash Balance $14.96M $16.33M $7.48M $30.23M $30.23M
Net Change in Cash -$1.36M $8.85M -$22.75M $682,000.00 $15.89M
Beginning Cash Balance $16.33M $7.48M $30.23M $29.52M $14.32M
Effect of Exchange Rate Changes -$12,000.00 $1,000.00 -$3,000.00 $35,000.00 $20,000.00
Free Cash Flow $11.45M -$18.20M -$44.09M -$89.83M -$23.48M
Gain/Loss from Continuing Operations – – – $139.54M $0.00
Deferred Tax – – – $0.00 $0.00
Net Issuance Payments Of Debt – – – $92.82M -$654,000.00
Net Preferred Stock Issuance – – – -$537,000.00 –

Discussion

No comments yet — be the first to weigh in on PGEN.

Sign in to join the discussion.

Scroll to Top